CB-101

N/A

Report date: 2026/05/13 09:17:28

Base Information

Drug NameCB-101

Drug Alias NameCB-101

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionHLA-DR antigens-associated invariant chain agonistsCluster of differentiation 80 stimulants

TargetsHLA-DR antigens-associated invariant chainCluster of differentiation 80

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChimeron Bio

China Registration ClassN/A

Develop Information

Active CompaniesChimeron Bio

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A